Related Experiment Video
Updated: Aug 5, 2026

Tissue Triage and Freezing for Models of Skeletal Muscle Disease
Published on: July 15, 2014
Distal Myopathies and Beyond: An Updated Overview of the Welander Distal Myopathy
Ana García-Rubio1, Julia Sánchez De Los Santos1, José M Izquierdo1
1Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid (CSIC/UAM), Campus de Cantoblanco, C/Nicolás Cabrera 1, 28049 Madrid, Spain.
Abstract:
Myopathies are a heterogeneous group of disorders that primarily affect skeletal muscles and are classified as rare diseases owing to their low incidence. In particular, Welander distal myopathy is a rare, late-onset muscular disorder that was first described in 1951. Since then, substantial progress has been made in characterizing its clinical presentation and histopathological features. Despite these advances, many aspects of the disease, such as the underlying molecular mechanisms and factors driving phenotypic variability, remain unknown. Furthermore, the scarcity of reliable disease models not only limits the exploration of the molecular basis of the disease but also the development of effective treatments. In this review, we summarize the current knowledge of Welander distal myopathy and discuss potential directions in this field.
More Related Videos
06:12Dissection of the Transversus Abdominis Muscle for Whole-mount Neuromuscular Junction Analysis
Published on: January 11, 2014
06:35In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
Related Concept Videos
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Satellite Stem Cells and Muscular Dystrophy
Myasthenia Gravis ll: Pathophysiology
Lysosomal Hydrolases
Cardiomyopathy II: Dilated Cardiomyopathy
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...